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Abstract
Murine models of allergic asthma have been used to understand the mechanisms of development and pathology in this
disease. In addition, knockout mice have contributed significantly to our understanding of the roles of specific molecules
and cytokines in these models. However, results can vary significantly depending on the mouse strain used in the model,
and in particularly in understanding the effect of specific knockouts. For example, it can be equivocal as to whether specific
gene knockouts affect the susceptibility of the mice to developing the disease, or lead to resistance. Here we used a house
dust mite model of allergic airway inflammation to examine the response of two strains of mice (C57BL/6 and BALB/c) which
differ in their responses in allergic airway inflammation. We demonstrate an algorithm that can facilitate the understanding
of the behavior of these models with regards to susceptibility (to allergic airway inflammation) (Saai) or resistance (Raai)i n
this model. We verify that both C57BL/6 and BALB/c develop disease, but BALB/c mice have higher Saai for development. We
then use this approach to show that the absence of the Tec family kinase Itk, which regulates the production of Th2
cytokines, leads to Raai in the C57BL/6 background, but decreases Saai on the BALB/c background. We suggest that the use
of such approaches could clarify the behavior of various knockout mice in modeling allergic asthma.
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Introduction
Mouse models have played significant roles in our understand-
ing of the immunological mechanism(s) leading to the develop-
ment of allergic airway inflammation. However, various strains of
mice respond differently in these models, and there are more than
a few examples of gene knockouts that display contrasting
phenotypes in different backgrounds [1,2]. This is exemplified
by the known differences in behavior between C57BL/6 and
BALB/c backgrounds in models of allergic airway inflammation
[3]. For example, analysis of IL-5 or T-bet knockouts, or the
absence of eosinophils, has revealed differences in responses
dependent on whether they are on a C57BL/6 or BALB/c
background [4,5,6,7,8]. As a result, it is currently difficult to
evaluate without ambiguity, the roles of specific molecules in this
disease.
In theoretical and empirical infectious disease models, the
concept of tolerance (T) and resistance (R) has been developed [9].
This concept states that animals that are infected with a pathogen
may vary in their response, which can be one of complete
resistance, i.e. animals are resistant to developing symptoms of an
infection. Alternatively, animals can vary in tolerance, such that
the symptoms that develop after infection can be mild, and such
animals would be said to have a high tolerance, while animals that
have severe symptoms would be said to have low tolerance [9].
However, these responses do not address whether animals are
susceptible, i.e. able to be infected by the pathogen, or the
mechanisms behind their responses. In this case, one can surmise
that a tolerant animal mobilizes immune mechanisms to blunt the
pathological effects of the infection and so has varying degrees of
tolerance. By contrast, a resistant animal may either rapidly
reduce pathogen infection, or rapidly down modulate immune
mediated pathological responses such that they are viewed as
resistant (to developing symptoms). In both cases, the mechanisms
can be potentially traced to the presence of robust immune
responses.
Here we suggest that similar models could be applied to study
diseases like allergic airway inflammation, in which the trigger for
disease is not necessarily an infectious agent. In this case, we
propose that animals that have mild symptoms of the disease have
low susceptibility (Saai,Sfor susceptibility with subscript aai to
denote the disease, allergic airway inflammation, being analyzed),
while animals with elevated symptoms have high susceptibility.
Animals with no symptoms are resistant (Raai,Rfor resistant with
subscript aai to denote the disease being analyzed). In the first case
of animals with varying degrees of susceptibility, this may be
related to the nature and intensity of the immune mediated
pathology, while in the second case, this could be related to either
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mediated pathology. While all susceptible animals develop
symptoms, analyzing the degrees of susceptibility could allow for
discrimination of responses that is not currently appreciated with
simple scoring of susceptible and resistant. Decreasing susceptibil-
ity (e.g. by pharmaceutical approaches) may be enough to
significantly reduce pathology.
We suggest that strain specific differences in responses in allergic
airway inflammation models may be due to differences in degrees
of susceptibility (degrees of response), or resistance (lack of
response or strong down modulation of the immune mediated
pathology). It would also be useful to be able to categorize the
effects of gene knockouts based on these two parameters, rather
than merely susceptible and resistant, since targeting such genes
could be an approach to decrease susceptibility and symptoms. In
this case, an animal with high Saai would develop allergic airway
inflammation at low doses of allergen, while one with low Saai
would require higher doses. By contrast, an animal that is resistant
(Raai) would not develop symptoms regardless of allergen dose.
However, thresholds for allergen exposure and development of
disease would have to be established. Experiments that vary
antigenic exposure could be used to determine whether strains or
gene knockouts have increased or decreased tolerance, or
resistance.
Ovalbumin (OVA) sensitization is a popular model for allergic
airway inflammation. This model is well established and results in
the development of allergic airway inflammation [10]. OVA is
initially administered with the adjuvant aluminum hydroxide
(Alum) via intraperitoneal injections. The mice are then
challenged with antigen OVA by respiratory exposure which
triggers the onset of symptoms of the disease [10]. However, this
model has limitations, including the fact that it may not reflect
natural routes of allergen exposure. In addition, long term
exposure to OVA results in the development of tolerance, thus
reducing the flexibility in experiments that seek to address varying
antigen concentrations [11,12,13,14]. The house dust mite (HDM)
species Dermatophagoides pteronyssinus is a perennial indoor allergen
and it is known to exacerbate the symptoms of allergic airway
inflammation in patients. HDM causes airway inflammation in at
least 10 percent of the general population, and it is known to
exacerbate asthmatic symptoms in 90 percent of humans
[15,16,17,18]. In mouse models, exposure to whole HDM extracts
results in the development of allergic airway inflammation, even
without prior sensitization (as is required for OVA) [19]. In
addition, chronic exposure does not result in the development of
tolerance as is typically observed with OVA [19].
The tyrosine kinase Interleukin-2 Inducible T cell kinase (Itk)
plays an important role in the development of Th2 type responses
[20,21,22,23]. Using mouse models of allergic airway inflamma-
tion as models of allergic asthma, we have previously shown that
Itk plays an important role in the induction of Th2 and Th17
responses that regulate the development of this disease
[24,25,26,27,28]. On the C57BL/6 background, we have reported
that the absence of Itk abrogates the development of various
symptoms associated with the model of allergic asthma such as
airway hyperresponsiveness, mucous production, lymphocyte
infiltration and inflammatory cytokine production [29]. We
previously used the well established model allergen, ovalbumin
(OVA) in these studies, however, as mentioned previously, there
are some limitations to this model.
Here we have used HDM extracts in a model of allergic airway
inflammation, along with WT and Itk null mice on both C57BL/6
and BALB/c background, to determine whether mice lacking Itk
are resistant or have reduced susceptibility to the development of
allergic airway inflammation. We developed a mathematical
model to determine resistance versus susceptibility, and show that
as previously suggested, C57BL/6 mice exhibit reduced suscep-
tibility to developing allergic airway inflammation compared to
BALB/c mice. However, on the C57BL/6 background, the
absence of Itk results in resistance, but on the BALB/c background
results in reduced susceptibility. Our approach also provides a
generalized approach to determining whether the absence of
specific genes in mice affect susceptibility to developing allergic
airway inflammation.
Results
Analysis of airways hyperresponsiveness in C57BL/6 and
BALB/c mice in response to HDM extract
Mouse models of allergic asthma have played crucial roles in
our understanding of this disease in humans. However, the mouse
strains that are used sometimes respond differently to the same
stimulus. Due to the availability of multiple knockouts, two of the
most common strains used in asthma models are based on the
C57BL/6 and BALB/c mice strains. These studies have indicated
that BALB/c mice have a more robust development of allergic
airway inflammation than the C57BL/6 [2]. The response of these
animals to varying doses of allergen may be able to provide
information regarding the nature of these responses (e.g. there may
be a difference in the doses required to elicit a response in the
various strains, or in knockouts). A large majority of studies of
mouse models of allergic airways disease utilize the Ovalbumin/
Alum model. However, it is difficult to use this approach when
examining dose responses since prolonged airway exposure of
mice to OVA results in the development of tolerance and a
subsequent reduction in airway inflammation [19]. By contrast,
exposure of mice to extracts of HDM does not result in the
development of tolerance [19]. HDM also has the advantage of
being a bona fide allergen to which humans develop allergic and
asthmatic responses [30]. We therefore used this allergen to
examine the dose responsiveness of C57BL/6 and BALB/c mice
in the development of allergic airway inflammation.
We challenged WT C57BL/6 and BALB/c mice with
increasing doses (5, 25 and 100 mg/mouse delivered intranasally)
of HDM over 10 days. Twenty four hours after the last exposure,
we analyzed the mice for airways hyperresponsiveness (AHR).
This analysis revealed that WT BALB/c mice had higher AHR
than WT C57/Bl/6 mice (Fig. 1a–c). However, although both
strains had increased AHR responses as the HDM dose increased,
there was a limited dose response (Fig. 1a–c).
Analyzing the area under the curve (AUC) of the airways
resistance measurements provided information as to the dose
dependence of these responses. The data (Fig. 1d) showed that the
BALB/c strain exhibited moderate dose dependence in the AUC
for AHR measurements. By contrast, the C57BL/6 mice had little
dose response. Analysis of the slopes of the AUC revealed that this
was not a good parameter to use for analysis of dose responses,
since these slopes were not significantly above 0, suggesting limited
dose responsiveness in AHR to HDM exposure.
Analysis of lung pathology in C57BL/6 and BALB/c mice
in response to HDM extract
Analysis of lung sections from these mice revealed that both
C57BL/6 and BALB/c mice exhibited patterns of lung inflam-
mation and mucous production that reflects the predominant Th2
nature of the response (Fig. 2). However, while there was no
apparent dose dependency in this pathology in the WT mice, the
Susceptibility in AAI
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compared to C57BL/6 mice.
BALB/c mice have greater Th2 cytokine responses than
C57BL/6 mice in a HDM induced model of allergic airway
inflammation
We collected lungs from the HDM exposed C57BL/6 and
BALB/c mice and analyzed the expression of the Th2 cytokines
IL-5, and -13, and the Th1 cytokine IFN-c. Figure 3 shows the
expression of these cytokines in these two mouse strains. We
observed that BALB/c mice generated a robust dose-dependent
increase in IL-4 production, while in C57BL/6 mice the response
was lower (Fig. 3a, note log scales). Similar results were observed
when we analyzed IL-13 expression (Fig. 3b). By contrast, while
C57BL/6 mice generated little dose dependent increases in the
Th1 cytokine IFN-c, BALB/c mice generated more robust dose
dependent increases in this cytokine (Fig. 3c).
Analysis of the chemokines CCL7 and CCL11 revealed similar
trends, in that WT BALB/c mice had significant dose dependent
increases in the expression of these 2 chemokines, although less
robust than Th2 cytokine (Fig. 4, note log scales). These data
support the view that BALB/c mice generally exhibit enhanced
responses to allergic airway inflammatory stimuli.
Mice lacking Itk on the C57BL/6 background exhibit
reduced responses to HDM induced development of
allergic airway inflammation compared to those on the
BALB/c background
Mice lacking the Tec family kinase Itk on either C57BL/6 or
BALB/c background have T cells that are defective in secretion of
Th2 cytokines [20,21,22,23]. We have previously reported that
mice lacking Itk on the C57BL/6 background do not develop
symptoms of allergic asthma using an OVA model of this disease
[27,29]. Here we have compared mice lacking Itk on both
C57BL/6 and BALB/c backgrounds using the HDM dose model
described above against their WT counterparts. We have
previously reported that in the absence of Itk, C57BL/6 mice do
not develop allergic airway disease using the OVA model
[26,27,29,31]. Analysis of Itk null mice on both genetic
backgrounds revealed reduced AHR responses, and the responses
of Itk null mice on a C57BL/6 background were more
pronounced than those on the BALB/c background (Fig. 1a–c).
Itk null mice on both C57BL/6 as well as Balb/c backgrounds
exhibited very little lung inflammation, even at the highest
concentration of HDM used (100 mg) (Fig. 2). As noted for the
WT counterparts, there was limited dose responsiveness observed
in these parameters.
Figure 1. Airways hyperresponsiveness dose response to house dust mite exposure. The indicated strains of mice (B6=C57BL/6;
Bc=BALB/c; B6 Itk
2/2= C57BL/6/Itk
2/2; Bc Itk
2/2= BALB/c/Itk
2/2) were exposed to A)5 ;B) 25; and C) 100 mg of HDM per day for 10 consecutive
days. Twenty four hours after the final exposure, animals were analyzed for hyperresponsiveness to increasing doses of methacholine as described in
the materials and methods section (*p,0.05, Bc vs. B6, Bc vs. Bc Itk
2/2 , B6 vs. B6 Itk
2/2, Bc Itk
2/2 vs. B6 Itk
2/2, 1-way ANOVA). D) The Area Under
the Curve (AUC) was determined for the methacholine response at each dose of HDM.
doi:10.1371/journal.pone.0011348.g001
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C57BL/6 background had significantly reduced cytokine and
chemokine responses to HDM compared to WT C57BL/6 mice
(Fig. 3a–c). In addition, Itk null mice on the BALB/c background
had significantly reduced cytokine and chemokine responses to
HDM compared to WT BALB/c mice (Fig. 3a–c). However,
comparing the responses of Itk null mice on the C57BL/6
background to those on the BALB/c background indicated that
the Itk null BALB/c mice still exhibited some response to HDM
exposure compared to the Itk null C57BL/6 mice (Fig. 3a–c).
These data support the view that Itk plays a critical role in this
response, but the severity varies dependent on the genetic
background of the mice.
C57BL/6 mice have low susceptibility while BALB/c mice
have high susceptibility to developing allergic airway
inflammation
Given these differential responses between C57BL/6 and
BALB/c mice, and in the absence of Itk, we attempted to
determine whether the absence of Itk led to reduced susceptibility
in developing allergic airway inflammation, or resistance. We
developed an approach to analyze the response of these mice
and place them into categories of varying susceptibility (Saai)o r
resistance (Raai). This approach takes advantage of dose
dependent responses in the airways in mice exposed to HDM.
The slope of these responses provides a simple parameter that
determines whether these animals are responding (i.e. if the slopes
Figure 2. Histopathological analysis of the dose response to house dust mite exposure. The indicated strains of mice were exposed to
HDM as in figure 1. Twenty four hours after the final exposure, animals were sacrificed and lungs collected for A) H&E staining or B) PAS staining. All
images are at 106.
doi:10.1371/journal.pone.0011348.g002
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animals are responding, Fig. 5a). The p values of these slopes (i.e.
whether they are significantly above 0) are collected, transformed
(1/average –Logp, see materials and methods) and used to
determine whether the response of the mice are indicative of
degrees of susceptibility (Saai) or resistance (Raai). The assumption
is that the slopes of the responses to HDM will be significantly
higher than 0 if mice are responding (with corresponding
decreases in p values), regardless of their susceptibility. By
contrast, mice that do not respond will have slopes that are not
significantly different from 0 (with p values .0.05), and so are
resistant. The extent to which mice respond is captured by the
level of significance of the slopes of their responses (i.e. in the p
values). A non-biased analysis would reveal mice with varying
degrees of susceptibility (Saai) versus resistant mice (Raai)u s i n ga
cutoff of .0.77 for Raai (1/-Log 0.05, assuming p value ,0.05 as
significant), and ,0.77 if mice are Saai, with values approaching
0.77 interpreted as decreasing susceptibility towards resistance.
Thus susceptible animals will have values of ,0.77, while
resistant mice will have values .0.77.
We rescaled the data shown in figures 3 and 4 to derive simple
properties that describe the relationship between the doses of
HDM and the cytokine responses of the different strains of mice.
Analysis of the slopes of the cytokine and chemokine responses of
the WT strains revealed that IL-4 and IL-13 responses in the
C57BL/6 mice were much lower than the BALB/c mice (lower
slopes, Fig. 5b), although both responses had slopes that were
statistically significantly above 0 (p,0.05 both strains and
cytokines). Analysis of CCL7 responses revealed similar behavior
(p,0.05, slopes significantly above 0) (Fig. 5b). However, analysis
of CCL11 revealed a different behavior, with slopes that were not
significantly different from 0 in the two strains of mice. This
suggested that CCL11 did not behave in a dose dependent manner
that would be useful in determining Saai or Raai,( Fig. 5b). By
contrast, the IFN-c response had small slopes (reflecting little
change versus dose), although the slope was significantly above 0
in the BALB/c mice (p,0.05), but not in C57BL/6 mice,
confirming the predominant Th2 nature of this response (Fig. 5b).
Combining these data (i.e. the IL-4, -13, CCL7 and 11
responses using the formula described in the materials and
methods) revealed that while C57BL/6 mice are not resistant to
HDM induced allergic airway inflammation, they have fairly low
susceptibility values compared to BALB/c mice, which have high
susceptibility values (Fig. 5c). Note that inclusion of the IFN-c
response does not change this conclusion, but reduces the
separation between the strains.
Figure 3. Airway cytokine dose response to house dust mite exposure. A) The indicated strains of mice were exposed to HDM as in figure 1,
then sacrificed 24 hours after the final exposure and lungs collected for mRNA analysis. Q-RT-PCR analysis was performed for A) IL-4, B) IL-13 and C)
IFN-c. Data were normalized to PBS exposed animals and expressed as fold increased over the PBS controls (which was set at 1). (Note log scales on
both y- and x-axes,* p ,0.05, Bc vs. B6,
{p,0.05, Bc vs. Bc Itk
2/2,
#B6 vs. B6 Itk
2/2,
@p,0.05, Bc Itk
2/2 vs. B6 Itk
2/2, students t-test).
doi:10.1371/journal.pone.0011348.g003
Figure 4. Airway chemokine dose response to house dust mite exposure. A) The indicated strains of mice were exposed to HDM as in
figure 1, then sacrificed 24 hours after the final exposure and lungs collected for mRNA analysis. Q-RT-PCR analysis was performed for A) CCL-7, B)
CCL-11 and Data were normalized to PBS exposed animals and expressed as fold increased over the PBS controls as in figure 1. (Note log scales on
both y- and x-axes,* p ,0.05, Bc vs. B6,
{p,0.05, Bc vs. Bc Itk
2/2,
#B6 vs. B6 Itk
2/2,
@p,0.05, Bc Itk
2/2 vs. B6 Itk
2/2, students t-test).
doi:10.1371/journal.pone.0011348.g004
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development of allergic airway inflammation dependent
on the background strain
We next applied these analyses to the strains lacking Itk, and the
results were quite revealing. When compared to their WT
counterpart, the cytokine and chemokines responses in Itk null
mice, on the C57BL/6 background, had slopes that were not
significantly above 0 (p.0.05, Fig. 5a). By contrast, although the
cytokine and chemokine responses in Itk null mice on the BALB/c
background had smaller slopes than their WT counterparts, with
the exception of IL-4, they were significantly above 0 (p,005 for
IL-13, CCL7 and CCL11, Fig. 5b). Combining these data
resulted in Saai values supporting a conclusion that on the C57BL/
6 background, the absence of Itk results in resistance to HDM
induced allergic airway inflammation (Fig. 5c). By contrast, on
the BALB/c background, the absence of Itk results in reduced
susceptibility to HDM induced allergic airway inflammation
(Fig. 5c). Euclidean hierarchical clustering of these values
generates dendrograms that support these conclusions in that the
C57BL/6 and C57BL/6/Itk
2/2 mice clustered close together, the
BALB/c/Itk
2/2 mice clustered close to the C57BL/6, and the
BALB/c mice were further apart (Fig. 5d). These analyses suggest
that on the C57BL/6 background, the absence of Itk results in
Figure 5. Itk regulates the development of susceptibility or resistance to allergic airway inflammation dependent on background.
A) Model of data analysis. Strain 1 and 2 differ with regards to their dose response to allergen. This difference can be captured by the slope of their
dose response (Left panel), the significance of which can inform on whether there is a response (p,0.05) or not (p.0.05) (right panel). These p values
can be used as described in the text to determine resistance (R), i.e. no response (with p.0.05,) or the degrees of susceptibility (with p,0.05), which is
related to the slope of their response, and thus the p values of those slopes. B) Analysis of the slopes of the IL-4, IL-13 and IFN-c (left panel) or CCL-7
and CCL-11 (middle panel) dose responses for the indicated mice. Analysis of the inverse of the slopes of the data shown in (A) (right panel, note log
scales on the y-axis). C) Analysis of Susceptible (Saai) or Resistance (Raai) as described in thematerials and methods . The dotted line indicates the
cutoff of 0.77 between resistance and susceptibility. D) Hierarchical clustering of the values in (C) to generate a cluster tree (B6=C57BL/6; Bc=BALB/
c; B6/Itk
2/2= C57BL/6/Itk
2/2; Bc/Itk
2/2= BALB/c/Itk
2/2).
doi:10.1371/journal.pone.0011348.g005
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inflammation. By contrast, on the BALB/c background, the
absence of Itk reduces the susceptibility of the mice, but they are
not resistant.
Discussion
Mouse models have played significant roles in our understand-
ing of the immunological mechanisms leading to the development
of allergic airway inflammation, and are therefore used as models
of allergic asthma [2]. Here we compare two commonly used
strains in such studies, the C57BL/6 and BALB/c strains, as well
as the absence of the Tec family kinase Itk, which regulates
effective Th2 responses in models of HDM induced allergic
inflammation. Using a new approach to compare whether animals
are resistant or have varying degrees of susceptibility to developing
allergic airway inflammation, we demonstrate that both strains of
mice are sensitive to developing allergic airway inflammation, but
that C57BL/6 mice are less susceptible than BALB/c mice. By
contrast, we show that in the absence of Itk, C57BL/6 mice
become resistant, while on the BALB/c background, these mice
have reduced susceptibility, but are not resistant. We suggest that
this approach could be used to compare the behavior of various
strains of mice and knockouts in allergic inflammation.
We have developed this method based on the model of
tolerance and resistance in infectious disease, however, we use
susceptibility and resistance (with a subscript that denotes the
disease being analyzed (hence Saai and Raai). In infectious disease
models, the concept of tolerance (T) and resistance (R) states that
animals that are infected with a pathogen may vary in their
response, which can be one of complete resistance, i.e. animals are
resistant to developing symptoms of an infection or vary in
tolerance, such that the symptoms that develop after infection can
be severe or mild [9]. We suggest that diseases caused by an
immune response, such as allergic airway inflammation, can also
be characterized using similar terms. However, in this case,
susceptible animals that have mild symptoms of the disease have
low susceptibility (Saai), while animals with elevated symptoms have
high susceptibility, and animals that show no symptoms are
resistant (Raai). Importantly, we do not use these terms to suggest a
mechanism, but rather the type of response. Furthermore we
provide a method to distinguish between susceptible and resistant
animals and score their degree of susceptibility to developing
symptoms of allergic airway inflammation. When applied to
knockout models, this model would allow for the determination of
whether a particular gene plays a role in resistance, or decreases
symptoms and thus modulates susceptibility. While this could be
due to multiple potential mechanisms, pharmaceutical targeting of
genes involved in susceptibility may represent better approaches,
particularly since they would be able to reduce symptoms (reduce
susceptibility), and would perhaps be less likely to have significant
effects on other immune responses.
A number of studies have used various approaches to examine
strains of mice for their susceptibility to developing airway
inflammation [32]. Most of these studies use subjective criteria
for determining resistance or susceptibility. However, while
resistance is fairly straightforward to identify (e.g. the lack of
response), there is not a good way to determine varying degrees of
susceptibility. In addition, most studies use allergens at single
doses, and it is always possible that at other doses, animals that
may seem resistant are actually susceptible, but simply with
reduced susceptibility. While a number of studies have compared
different strains of mice, and looked at multiple parameters for
severity of response (e.g. in [33]), this is usually done using the
Ovalbumin model of allergic airway inflammation, which makes it
difficult to examine dose responses. A few studies have examined
dose responses in the immune response to Ovalbumin, but using
different immunizing doses, rather than varying the respiratory
exposure. While such analyses are interesting (e.g. immunizing
with low doses of ovalbumin in alum predisposes to Th2 responses,
while higher doses predispose to Th1 responses [34]), they
generally may not represent how humans are sensitized during
the development of asthma. The approach used here addresses
these concerns by using varying doses of allergen, and combining
the responses into one parameter that correlates well with the
known behavior of the two strains of mice tested. Validating this
approach, we show that dependent on the strain background,
absence of the Tec kinase Itk, which regulates Th2 cytokine
secretion, either leads to resistance (on a C57BL/6 background) or
reduced susceptibility (on a BALB/c background). We suggest that
such an approach could also be used in outbred populations
including humans, where multiple responses could be combined to
provide a single parameter that describes resistance or varying
degrees of susceptibility to allergic airway inflammation, or other
responses with complex components.
Materials and Methods
Mice
WT (C57BL/6 and BALB/c, initially procured from the
Jackson Labs) and Itk null mice (on a C57BL/6, kindly provided
by Dr. Dan Littman, and BALB/c [35]) were aged between 6–12
weeks old for all these studies. All mice were backcrossed to the
respective backgrounds at least 10 generations. All the experiments
were approved by the Office of Research Protection’s Institutional
Animal Care and Use Committee at Pennsylvania State University
(protocol # 30752).
Induction of Experimental Allergic Asthma
We induced allergic airway disease by exposing the mice
intranasally to 5, 25, 100 mg of whole HDM extract (Greer
Laboratories, Lenoir, NC) resuspended in PBS. Mice were
exposed daily for 10 consecutive days, and 24 hours after the
final HDM exposure, analyzed for airways hyperresponsiveness,
then sacrificed, samples collected for histology, and RNA obtained
from lungs as detailed below.
Analysis of AHR
AHR was analyzed using a flexivent apparatus twenty-four
hours after the final HDM challenge. Mice were analyzed for
airway hyperresponsiveness using the mechanical ventilator
apparatus in response to PBS or increasing doses of aerosolized
methacholine from 1 mg/mL to 100 mg/mL as described
[29,36,37]. Respiratory system resistance (Rrs) values (cm/H20/
ml) were plotted vs. methacholine concentration.
Histology
After AHR analysis, lungs were fixed with 4% formaldehyde
and embedded in paraffin wax and cut into thin sections. The
sections were then fixed onto slides and stained with Hematoxylin
and Eosin (H&E) to examine inflammation, and the level of
mucous production determined by using periodic acid-Schiff (PAS)
stain.
Quantitative RT-PCR analysis
Twenty-four hours after the last HDM challenge, total RNA
was isolated from lung tissue using Trizol reagent (Invitrogen Life
Technologies). Total RNA (5 mg) was reverse transcribed to cDNA
Susceptibility in AAI
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Strand Beads following manufacturer’s instructions (Amersham
Biosciences, Piscataway, NJ). PCR was performed in triplicate on
an Applied Biosystems ABI PRISM 7300 Sequence Detection
System using Taqman Universal PCR master mix with commer-
cially available primers and FAM labeled probes (Assays on
Demand
TM, Applied Biosystems). Relative quantification was
performed using the Comparative CT (threshold cycle) method
which uses the arithmetic formula 2
2DDCT to represent the
amount of target gene, normalized to an endogenous reference
(GAPDH, in our case) and relative to a calibrator sample. The
DCT value is determined by subtracting the average GAPDH CT
value from the average target gene CT value. The DDCT value is
then calculated by subtracting the DCT value of the chosen
calibrator sample from the DCT value of the target gene. The
relative gene expression levels were then determined from the
equation 2
2DDCT.
Data analysis
Statistical evaluation was conducted by using Student’s t test
with a probability value of P # 0.05 considered statistically
significant. Analysis of the slopes of the dose responses were
performed using Graphpad Prizm (note that while the data shown
in figure 3 and 4 are log plotted, the slopes were determined using
all values). If the p values of those slopes are statistically significant,
this indicates that the animals responded in a dose dependent
fashion since the slopes are significantly non-zero. We then derived
the inverse of the average of the 2Log10 of the p values of the
slopes (i.e. 1/avg(–Log10p(n), where n is the number of responses
measured, in this case, the IL-4, IL-13, CCL7 and CCL11
responses). The assumption is that the slopes of the responses to
HDM will be significantly higher than 0 if mice are responding
(with corresponding decreases in p values), even if they have low
susceptibility to HDM (and thus respond poorly). By contrast,
mice that do not respond will have slopes that are not significantly
different from 0 (with p values .0.05), and so are resistant. The
extent to which mice respond is captured by the level of statistical
significance of the slopes of their responses (i.e. in the p values). A
non-biased analysis would reveal susceptible mice, with varying
degrees of susceptibility (Saai) versus resistant mice (Raai) using a
cutoff of .0.77 for R (1/2Log 0.05, assuming p value ,0.05 as
significant) and ,0.77 if mice are S, with values approaching 0.77
interpreted as decreased susceptibility. Animals were considered
susceptible (Saai) if this value is ,0.77 and resistant (Raai) if this
number is .0.77. Generation of slopes, p values and statistically
analyses were performed using Graphpad Prizm and Microsoft
Excel. Hierarchical clustering was performed with SysSTAT
(SysSTAT Software) using the same numbers generated as
described above (i.e. 1/avg(–Log10p(n)).
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